Table 1.
Genotype | Sex | N | Large intestine tumor multiplicity | Large intestine tumor incidence | Duodenum tumor multiplicity | Duodenum tumor incidence | Ileum tumor multiplicity | Ileum tumor incidence |
---|---|---|---|---|---|---|---|---|
Muc2−/– | M | |||||||
Combined | 29 | 3.6 ± 2.9 | 90% | 0.9 ± 1.2 | 45% | 2.3 ± 3.4 | 55% | |
30 weeks | 15 | 2.6 ± 1.8 | 87% | 0.3 ± 0.6 | 20% | 2.5 ± 3.5 | 60% | |
60 weeks | 14 | 5.4 ± 3.1 | 100% | 1.6 ± 1.1 | 70% | 1.9 ± 3.4 | 50% | |
Muc2−/– Pla2+ | M | |||||||
Combined | 18 | 0.4 ± 0.6 | 33% | 0.5 ± 0.5 | 33% | 0.2 ± 1.2 | 5% | |
30 weeks | 10 | 0.3 ± 0.4* | 30% | 0.3 ± 0.5 | 30% | 0 | 0 | |
60 weeks | 8 | 0.5 ± 0.8** | 38% | 0.8 ± 1.0*** | 38% | 0.5 ± 1.7 | 13% | |
Muc2−/– | F | |||||||
Combined | 21 | 1.5 ± 1.7 | 62% | 0.3 ± 0.6 | 19% | 1.8 ± 2.3 | 52% | |
30 weeks | 8 | 2.6 ± 1.6 | 100% | 0.4 ± 1.7 | 25% | 0.9 ± 2.8 | 25% | |
60 weeks | 13 | 0.8 ± 1.4 | 33% | 0.2 ± 0.7 | 15% | 2.3 ± 2.3 | 70% | |
Muc2−/– Pla2+ | F | |||||||
Combined | 21 | 0.1 ± 0.6 | 5% | 0 | 0 | 1.2 ± 2.3 | 33% | |
30 weeks | 14 | 0.2 ± 0.8 | 7% | 0 | 0 | 0.3 ± 0.6 | 21% | |
60 weeks | 7 | 0 | 0 | 0 | 3.0 ± 1.5 | 57% |
P = 0.03;
P = 0.0001;
P = 0.21.
P‐values compare age and sex matched classes. N = number of mice.